Data can help, but simply accessing more data only muddies your decision making. With Covance, you get the right analysis on the right data to empower your studies.

1. REAL-TIME
REAL-WORLD
PROPRIETARY
DATA. UNRIVALED
EXPERTISE.
IMPACTFUL RESULTS WITH COVANCE
Up to 60% of clinical development time and 40% of cost are spent on patient
recruitment. Data can help, but simply accessing more data only muddies your
decision making. With Covance, you get the right analysis on the right data to
empower your studies. Recruit eligible patients that fit your protocol faster,
identify and secure proven and/or new sites, forecast and measure progress
more efficiently. With Covance’s proprietary data, your program hits its mark.
Covance Inc. is the global drug development
business of Laboratory Corporation of America
Holdings (LabCorp). COVANCE is a registered
trademark and marketing name used by Covance
Inc. and its subsidiaries around the world.
*Average time savings based on an analysis of trials
processed through Covance Central Labs with Protocol
Finalization date after 1/1/2009 for the specific clinical
indications. Past performance is not a guarantee of future
results, and a variety of factors other than CRO
performance can impact timing of clinical studies.
*Protocol Finalization to Last Patient In Phase I-IV.
The Americas +1.888.COVANCE (+1.888.268.2623)
+1.609.452.4440 or +1.910.338.4760
Europe/Africa +00.800.2682.2682
+44.1423.500888 or +44.1753.512000
Asia Pacific +800.6568.3000 +65.6.5686588
© Copyright 2018 Covance Inc. INFCDS014-1118

2. REAL-TIME DATA. REAL-WORLD IMPACT.
TALK TO A REPRESENTATIVE TO FIND OUT HOW COVANCE CAN IMPACT YOUR STUDIES.
LEARN MORE AT COVANCE.COM/REALIMPACT
LABCORP DATA
Find Patients That Meet Your
Inclusion/Exclusion Criteria
Using LabCorp’s real world, de-identified
clinical laboratory data on over 150 million
patients, we can identify candidates who
meet your protocol’s eligibility criteria
and accurately model the impact that
the protocol inclusion/exclusion criteria
will have on the patient pool size.
CENTRAL LABS DATA
Pinpoint Investigators
Covance generates more clinical trial
data than anyone else in the world.
Our global proprietary data helps us
predict future investigator performance
and capacity to run multiple studies.
PATIENT DIRECT
A Direct Connection for
Finding Potential Participants
We have access to >150 million patients
and have a rapidly growing database
of people that have given us permission
to reach out directly to them for
participation in clinical studies.
PATIENT INTELLIGENCE
Strengthen Your Protocol
with Patient Insights
Design your protocol around
actual feedback from potential
patients to elevate your
recruitment and retention rates.
>2.5 Million
Processes
patient specimens per week
30 Billion*
test results
>5,000
diagnostic assays
including genotype data
>150 Million Patients >65,000
EMR interfaces
>5,000 ~1,900
Patient Service Centers
Global
Footprint
102 Countries
over 175,000 Sites
4.4 Million
kits shipped
per year
150 Million
Patients
in the patient pool
~30 Countries
Global VOP data collected across
10+ Indications
as of May, 2018
Every day our data grows,
deepening our insights to make
your studies more efficient.
Critical, patient-centric insights
extend your market outreach
and strengthen your studies.
~50%
of U.S. population
>15,000
historical protocols
Faster
Recruitment
by contacting patients directly
Rapidly
Growing
Database
14
Million
patients